Solving lymphoma's stem-cell problem

Nature. 2018 Nov;563(7731):S48-S49. doi: 10.1038/d41586-018-07364-3.
No abstract available

Keywords: Cancer; Medical research; Stem cells; Therapeutics.

MeSH terms

  • Adenine / analogs & derivatives
  • Agammaglobulinaemia Tyrosine Kinase / antagonists & inhibitors
  • Allografts / immunology
  • Autografts / immunology
  • Azetidines
  • B-Lymphocytes / drug effects
  • B-Lymphocytes / enzymology
  • B-Lymphocytes / immunology
  • Cell Separation
  • Drug Approval / legislation & jurisprudence
  • Fetal Blood / cytology
  • Fetal Blood / immunology
  • Graft vs Host Disease / complications
  • Graft vs Host Disease / immunology
  • Graft vs Host Disease / pathology
  • Graft vs Host Disease / therapy*
  • Hodgkin Disease / complications
  • Hodgkin Disease / immunology
  • Hodgkin Disease / pathology
  • Hodgkin Disease / therapy*
  • Humans
  • Nitriles
  • Photopheresis
  • Piperidines
  • Problem Solving*
  • Purines
  • Pyrazoles / pharmacology
  • Pyrazoles / therapeutic use
  • Pyrimidines / pharmacology
  • Pyrimidines / therapeutic use
  • Stem Cell Transplantation / adverse effects*
  • Sulfonamides
  • T-Lymphocytes, Regulatory / immunology
  • T-Lymphocytes, Regulatory / transplantation
  • United States
  • United States Food and Drug Administration / legislation & jurisprudence

Substances

  • Azetidines
  • Nitriles
  • Piperidines
  • Purines
  • Pyrazoles
  • Pyrimidines
  • Sulfonamides
  • ibrutinib
  • ruxolitinib
  • Agammaglobulinaemia Tyrosine Kinase
  • baricitinib
  • Adenine